CoverageForm 410-K10-Q8-K13D13G13F

Boyce Sarah

CIK 0001629383
President and CEODirector

Filings

33

Latest Mar 2, 2026

Issuers covered

5

Showing

33 of 33

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Boyce Sarah. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Boyce Sarah has filed

TickerIssuerFilingsLast filed
RNAAvidity Biosciences, Inc.25Feb 27, 2026
OABIOmniab, Inc.4Jun 21, 2024
CTNMContineum Therapeutics, Inc.2Jun 26, 2025
RNAAtrium Therapeutics, Inc.1Mar 2, 2026
LGNDLigand Pharmaceuticals Inc1Jun 13, 2022

All filings

33 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue